Literature DB >> 17206676

Active and passive smoking in childhood is related to the development of inflammatory bowel disease.

Suhal S Mahid1, Kyle S Minor, Arnold J Stromberg, Susan Galandiuk.   

Abstract

BACKGROUND: The highest prevalence of smoking in the United States is in Kentucky, where smoking typically begins in childhood. The state has many patients who suffer from inflammatory bowel diseases (IBD). The primary aim of this study was to assess whether exposure to active and/or passive tobacco smoke in childhood is related to the likelihood of developing IBD.
METHODS: Recruited into this prospective study were a total of 672 participants (253 patients with Crohn's disease [CD], 177 patients with ulcerative colitis [UC], and 242 controls), all of whom were asked to complete the Behavioral Risk Factor Surveillance Survey modified by the addition of 4 questions on childhood passive smoke exposure.
RESULTS: Survey response rate was 84%. CD and UC patients were more likely than controls to begin smoking regularly by ages 10 and 15, respectively, suggesting that becoming a regular smoker at a younger age may be associated with a subsequent diagnosis of IBD. Smoking by age 10 was associated with an earlier age at diagnosis with UC, but not with CD. CD patients were more likely than controls to have prenatal smoke exposure (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.1-2.71) and were more likely to have passive smoke exposure during childhood, with 1 or both parents or other household members being smokers (OR, 2.04; 95% CI, 1.28-3.31).
CONCLUSIONS: Passive and active smoke exposure in childhood influences the development of IBD. A high incidence of this disease in a state with a high rate of cigarette smoking underscores the profound role of environmental factors in the etiology of these illnesses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206676     DOI: 10.1002/ibd.20070

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

Review 2.  The role of smoking in Crohn's disease as defined by clinical variables.

Authors:  Suhal S Mahid; Kyle S Minor; Patrick L Stevens; Susan Galandiuk
Journal:  Dig Dis Sci       Date:  2007-03-31       Impact factor: 3.199

3.  Role of the xenobiotic receptor in inflammatory bowel disease.

Authors:  Razvan Arsenescu; Violeta Arsenescu; Jian Zhong; Munira Nasser; Razvan Melinte; R W Cameron Dingle; Hollie Swanson; Willem J de Villiers
Journal:  Inflamm Bowel Dis       Date:  2010-09-27       Impact factor: 5.325

Review 4.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

5.  [Banning smoking without compromise is the only way out of misery].

Authors:  Freyja Maria Smolle-Jüttner
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 6.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 7.  Pharmacogenetic biomarkers of response in Crohn's disease.

Authors:  T M Linares-Pineda; M Cañadas-Garre; A Sánchez-Pozo; M Á Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2017-06-20       Impact factor: 3.550

8.  Secondhand smoke exposure and serum cytokine levels in healthy children.

Authors:  Karen M Wilson; Sarah C Wesgate; Jennifer Pier; Emily Weis; Tanzy Love; Katie Evans; Ashwani Chhibber
Journal:  Cytokine       Date:  2012-07-16       Impact factor: 3.861

9.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

Review 10.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.